FY21 Full Year Results Investor Presentation
Filed with ASX · · 26 pages · English
This presentation (Presentation) has been prepared solely for informational purposes by Lumos Diagnostics Holdings Limited (Company). The information contained in this document (“Document”) has been prepared by Lumos Diagnostics Holdings Limited (referred to as “Lumos” or “Company”). This Document is current as at the date of this Document and should be read in conjunction with other Lumos periodi
Lumos Diagnostics Holdings Ltd. on 6ix
In the deck
Earlier from Lumos Diagnostics
Later from Lumos Diagnostics
- FY21 Full Year Results
- U.S FDA Deprioritises EUA Application for CoviDx
- Economic Evaluation of FebriDx
- Update on Economic Evaluation of FebriDx
- Monthly Activities/Appendix 4C Cash Flow Report
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics